Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Update

Global X HealthTech ETF (NASDAQ:HEAL) was the target of a large drop in short interest in July. As of July 31st, there was short interest totaling 7,620 shares, a drop of 66.5% from the July 15th total of 22,725 shares. Approximately 0.7% of the company’s stock are sold short. Based on an average daily volume of 8,615 shares, the short-interest ratio is presently 0.9 days.

Hedge Funds Weigh In On Global X HealthTech ETF

A number of institutional investors and hedge funds have recently made changes to their positions in HEAL. Daiwa Securities Group Inc. purchased a new stake in shares of Global X HealthTech ETF in the 3rd quarter worth $11,239,000. WT Wealth Management increased its stake in shares of Global X HealthTech ETF by 14.7% in the first quarter. WT Wealth Management now owns 101,116 shares of the company’s stock worth $2,409,000 after purchasing an additional 12,945 shares in the last quarter. Flow Traders U.S. LLC purchased a new position in shares of Global X HealthTech ETF during the 3rd quarter valued at $368,000. Raymond James Financial Inc. purchased a new stake in Global X HealthTech ETF in the 3rd quarter worth $274,000. Finally, Citadel Advisors LLC purchased a new position in shares of Global X HealthTech ETF in the third quarter valued at about $216,000.

Global X HealthTech ETF Stock Performance

Shares of NASDAQ:HEAL opened at $29.32 on Friday. The business has a 50-day simple moving average of $27.44 and a two-hundred day simple moving average of $26.19. The firm has a market cap of $31.08 million, a price-to-earnings ratio of 42.80 and a beta of 1.10. Global X HealthTech ETF has a fifty-two week low of $23.00 and a fifty-two week high of $33.59.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.